Company Information

ZENOTECH LABORATORIES LTD.

NSE : NABSE : 532039ISIN CODE : INE486F01012Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE59.110.46 (+0.78 %)
PREV CLOSE ( ) 58.65
OPEN PRICE ( ) 58.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 26844
TODAY'S LOW / HIGH ( )58.60 60.90
52 WK LOW / HIGH ( ) 4581
NSE
This Company is not listed in NSE
Company SecretaryAbdul Gafoor Mohammad
Non Executive Independent DirectorKavita Shah
Chintan Jitendra Shah
Jagruti Prashant Sheth
Non Independent & Non Executive DirectorJignesh Anantray Goradia
Rakeshchandra Jagdishprasad Sinha
Azadar Hussain Khan
Incorporation Year : 15-06 1989

Registered Office :

Address : Survey No. 250-252,Turkapally Villag,Shameerpet Mandal Hyderabad,
Telangana-500078 .

Phone : 09032044584 / 585

Email :  info@zenotech.co.in 

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.